L-Arginine Pathway in COPD Patients with Acute Exacerbation: A New Potential Biomarker

References

• Celli BR, MacNee W, ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23:932–946.
   PubMed Web of Science ®Google Scholar
• Van Eeden S, Leipsic J, Paul Man SF, Sin DD. The relationship between lung inflammation and cardiovascular disease. Am J Respir Crit Care Med 2012; 186:11–16.
   PubMed Web of Science ®Google Scholar
• Wedzicha JA, Donaldson GC. Exacerbations of chronic obstructive pulmonary disease. Respir Care 2003; 48:1204–1213.
   PubMedGoogle Scholar
• Chen K, Inoue M, Wasa M, et al. Expression of endothelial constitutive nitric oxide synthase mRNA in gastrointestinal mucosa and its downregulation by endotoxin. Life Sci 1997; 61:1323–1329.
   PubMed Web of Science ®Google Scholar
• Luiking YC, Engelen MP, Deutz NE. Regulation of nitric oxide production in health and disease. Curr Opin Clin Nutr Metab Care 2010; 13:97–104.
   PubMed Web of Science ®Google Scholar
• Ricciardolo FL, Sterk PJ, Gaston B, Folkerts G. Nitric oxide in health and disease of the respiratory system. Physiol Rev 2004; 84:731–765.
   PubMed Web of Science ®Google Scholar
• Kelly RA, Balligand JL, Smith TW. Nitric oxide and cardiac function. Circ Res. 1996; 79:363–380.
   PubMed Web of Science ®Google Scholar
• Luiking YC, Poeze M, Ramsay G, Deutz NE. Reduced citrulline production in sepsis is related to diminished de novo arginine and nitric oxide production. Am J Clin Nutr 2009; 89:142–152.
   PubMed Web of Science ®Google Scholar
• Jeyabalan G, Klune JR, Nakao A, et al. Arginase blockade protects against hepatic damage in warm ischemia-reperfusion. Nitric Oxide 2008; 19:29–35.
   PubMed Web of Science ®Google Scholar
• Luiking YC, Hallemeesch MM, van de Poll MC,Dejong CH,de Jonge WJ, Lamers WH, Deutz NE. Reduced citrulline availability by OTC-deficiency in mice is related to reduced nitric oxide production. Am J Physiol Endocrinol Metab 2008; 295:E1315–1322.
   PubMed Web of Science ®Google Scholar
• Song MY, Zwemer CF, Whitesall SE, D'Alecy LG. Acute and conditioned hypoxic tolerance augmented by endothelial nitric oxide synthase inhibition in mice. J Appl Physiol 2007;102:610–5.
   PubMed Web of Science ®Google Scholar
• Yildirim AO, Bulau P, Zakrzewicz D, et al. Increased protein arginine methylation in chronic hypoxia: role of protein arginine methyltransferases. Am J Respir Cell Mol Biol 2006; 35:436–443.
   PubMed Web of Science ®Google Scholar
• Bulau P, Zakrzewicz D, Kitowska K, et al. Analysis of methylarginine metabolism in the cardiovascular system identifies the lung as a major source of ADMA. Am J Physiol Lung Cell Mol Physiol 2007; 292:L18–24.
   PubMed Web of Science ®Google Scholar
• Vallance P, Leiper J. Cardiovascular biology of the asymmetric dimethylarginine: dimethylarginine dimethylaminohydrolase pathway. Arterioscler Thromb Vasc Biol 2004; 24:1023–1030.
   PubMed Web of Science ®Google Scholar
• Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest 2003; 111:1805–1812.
   PubMed Web of Science ®Google Scholar
• Goodson NJ, Symmons DP, Scott DG, Bunn D, Lunt M, Silman AJ. Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary carebased inception cohort. Arthritis Rheum 2005; 52:2293–2299.
   PubMed Web of Science ®Google Scholar
• Lobo SM, Lobo FR, Bota DP et al. C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest 2003; 123:2043–2049.
   PubMed Web of Science ®Google Scholar
• Man P, Connett JE, Anthonisen NR, Wise RA, Tashkin DP, Sin DD. C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax 2006; 61:849–53.
   PubMed Web of Science ®Google Scholar
• Blake GJ, Ridker PM. Inflammatory bio-markers and cardiovascular risk prediction. J Intern Med. 2002; 252:283–294.
   PubMed Web of Science ®Google Scholar
• Molnar T, Papp V, Banati M, et al. Relationship between C-reactive protein and early activation of leukocytes indicated by leukocyte antisedimentation rate (LAR) in patients with acute cerebrovascular events. Clin Hemorheol Microcirc 2010; 44:183–192.
   PubMed Web of Science ®Google Scholar
• Cooke JP. Does ADMA cause endothelial dysfunction? Arterioscler Thromb Vasc Biol 2000; 20:2032–2037.
   PubMed Web of Science ®Google Scholar
• Memon L, Spasojevic-Kalimanovska V, Bogavac-Stanojevic N, et al. Assessment of endothelial dysfunction: the role of symmetrical dimethylarginine and proinflammatory markers in chronic kidney disease and renal transplant recipients. Dis Markers 2013; 35:173–180.
   PubMed Web of Science ®Google Scholar
• Zoccali C, Maas R, Cutrupi S, et al. Asymmetric dimethyl-arginine (ADMA) response to inflammation in acute infections. Nephrol Dial Transpl 2007; 22:801–806.
   PubMed Web of Science ®Google Scholar
• Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and metaanalysis. Thorax 2004;59(7):574–580.
   PubMed Web of Science ®Google Scholar
• Sin D, Lacy P, York E, Man SF. Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 170:760–765.
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO workshop report. Bethesda, National Heart, Lung and Blood Institute, April 2001; NIH Publication No. 2701:1-100. Last update 2008.
   Google Scholar
• Nonaka S, Tsunoda M, Imai K, Funatsu T. High-performance liquid chromatographic assay of NG-monomethyl-L-arginine, NG,NG-dimethyl-L-arginine, NG,NG’-dimethyl-L-arginine using 4-fluoro-7-nitro-2,1,3-benzoxadiazole as a fluorescent reagent. J Chromatogr A 2005; 1066:41–45.
   PubMed Web of Science ®Google Scholar
• Mengerink Y, Kutlán D, Tóth F, Csámpai A, Molnár-Perl I. Advances in the evaluation of the stability and characteristics of the amino acid and amine derivatives obtained with the o-phthaldialdehyde/3-mercaptopropionic acid and o-phthaldialdehyde/N-acetyl-L-cysteine reagents. High-performance liquid chromatography-mass spectrometry study. J Chromatogr A 2002; 949:99–124.
   PubMed Web of Science ®Google Scholar
• Di Gangi IM, Pirillo P, Carraro S, et al. Online trapping and enrichment ultra performance liquid chromatography-tandem mass spectrometry method for sensitive measurement of “arginine-asymmetric dimethylarginine cycle” biomarkers in human exhaled breath condensate. Anal Chim Acta 2012; 754:67–74.
   PubMed Web of Science ®Google Scholar
• Scott JA, Duongh M, Young AW, Subbarao P, Gauvreau GM, Grasemann H. Asymmetric dimethylarginine in chronic obstructive pulmonary disease (ADMA in COPD). Int J Mol Sci 2014; 15:6062–6071.
   PubMed Web of Science ®Google Scholar
• Nural S, Günay E, Halici B, Celik S, Ünlü M. Inflammatory processes and effects of continuous positive airway pressure (CPAP) in overlap syndrome. Inflammation 2013; 36:66–74.
   PubMed Web of Science ®Google Scholar
• Howell K, Costello CM, Sands M, Dooley I, McLoughlin P. L-Arginine promotes angiogenesis in the chronically hypoxic lung: a novel mechanism ameliorating pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2009; 296:L1042–1050.
   PubMed Web of Science ®Google Scholar
• Lüneburg N, Harbaum L, Hennigs JK. The endothelial ADMA/NO pathway in hypoxia-related chronic respiratory diseases. Biomed Res Int 2014; 2014:501612.
   PubMed Web of Science ®Google Scholar
• Sommer N, Dietrich A, Schermuly RT et al. Regulation of hypoxic pulmonary vasoconstriction: basic mechanisms. Eur Respir J 2008; 32:1639–1651.
   PubMed Web of Science ®Google Scholar
• Jiang DJ, Jia SJ, Yan J, Zhou Z, Yuan Q, Li YJ. Involvement of DDAH/ADMA/NOS pathway in nicotine-induced endothelial dysfunction. Biochem Biophys Res Commun 2006; 349:683–693.
   PubMed Web of Science ®Google Scholar
• Laursen BE, Dam MY, Mulvany MJ, Simonsen U. Hypoxia-induced pulmonary vascular remodeling and right ventricular hypertrophy is unaltered by long-term oral L-arginine administration. Vascul Pharmacol 2008; 49:71–76.
   PubMed Web of Science ®Google Scholar
• Chen MF, Xie XM, Yang TL, et al. Role of asymmetric dimethylarginine in inflammatory reactions by angiotensin II. J Vasc Res 2007; 44:391–402.
   PubMed Web of Science ®Google Scholar
• Wang J, Sim AS, Wang XL, Wilcken DE. L-arginine regulates asymmetric dimethylarginine metabolism by inhibiting dimethylarginine dimethylaminohydrolase activity in hepatic (HepG2) cells. Cell Mol Life Sci 2006; 63:2838–2846.
   PubMed Web of Science ®Google Scholar
• Chen B, Strauch K, Jin Y, Cui H, Nelin LD, Chicoine LG. Asymmetric dimethyl arginine does not inhibit arginase activity and is pro-proliferative in pulmonary endothelial cells. Clin Exp Pharmacol Physiol 2014; 41:469–474.
   PubMed Web of Science ®Google Scholar
• Wells SM, Buford MC, Migliaccio CT, Holian A. Elevated asymmetric dimethylarginine alters lung function and induces collagen deposition in mice. Am J Respir Cell Mol Biol 2009; 40:179–188.
   PubMed Web of Science ®Google Scholar
• Rus A, Peinado MA, Castro L, Del Moral ML. Lung eNOS and iNOS are reoxygenation time-dependent upregulated after acute hypoxia. Anat Rec (Hoboken) 2010; 293:1089–1098.
   PubMedGoogle Scholar
• Brusselle GG, Provoost S, Bracke KR, et al. Inflammasomes in respiratory disease: from bench to bedside. Chest 2014; 145:1121–1133.
   PubMed Web of Science ®Google Scholar
• Wells SM, Holian A. Asymmetric dimethylarginine induces oxidative and nitrosative stress in murine lung epithelial cells. Am J Respir Cell Mol Biol 2007; 36:520–528.
   PubMed Web of Science ®Google Scholar
• Ratnam S1, Mookerjea S. The regulation of superoxide generation and nitric oxide synthesis by C-reactive protein. Immunology 1998; 94:560–568.
   PubMed Web of Science ®Google Scholar
• Klein E, Weigel J, Buford MC, Holian A, Wells SM. Asymmetric dimethylarginine potentiates lung inflammation in a mouse model of allergic asthma. Am J Physiol Lung Cell Mol Physiol 2010; 299:L816–825.
   PubMed Web of Science ®Google Scholar
• Boota A., Zar H., Kim YM. et al. IL-1 beta stimulates super­oxide and delayed peroxynitrite production by pulmonary vascular smooth muscle cells. Am J Physiol 1996; 271:L932–L938.
   PubMed Web of Science ®Google Scholar
• Kinugawa K, Shimizu T, Yao A, et al. Transcriptional regulation of inducible nitric oxide synthase in cultured neonatal rat cardiac myocytes. Circ Res 1997; 81:911–921.
   PubMed Web of Science ®Google Scholar
• Hoffmann G, Czechowski M, Schloesser M, Schobersberger W. Procalcitonin amplifies inducible nitric oxide synthase gene expression and nitric oxide production in vascular smooth muscle cells. Crit Care Med 2002; 30:2091–2095.
   PubMed Web of Science ®Google Scholar
• Antonescu-Turcu AL, Tomic R. C-reactive protein and copeptin: prognostic predictors in chronic obstructive pulmonary disease exacerbations. Curr Opin Pulm Med 2009: 15:120–125.
   PubMed Web of Science ®Google Scholar
• Molnar T, Pusch G, Papp V, et al. The L-arginine pathway in acute ischemic stroke and severe carotid stenosis: temporal profiles and association with biomarkers and outcome. J Stroke Cerebrovasc Dis 2014; 23:2206–2214.
   PubMed Web of Science ®Google Scholar